Humana Inc. (NYSE:HUM) Receives $285.68 Average Price Target from Analysts

Shares of Humana Inc. (NYSE:HUM) have received an average recommendation of “Hold” from the twenty-two research firms that are presently covering the company, Marketbeat.com reports. Seventeen equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $285.68.

Several analysts recently weighed in on HUM shares. StockNews.com cut Humana from a “buy” rating to a “hold” rating in a report on Tuesday, March 18th. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. Truist Financial raised their price target on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th.

Humana Trading Down 0.2 %

Shares of Humana stock opened at $270.04 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The business has a fifty day simple moving average of $270.51 and a two-hundred day simple moving average of $274.93. Humana has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a market capitalization of $32.59 billion, a price-to-earnings ratio of 27.14, a P/E/G ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts forecast that Humana will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.31%. Humana’s dividend payout ratio (DPR) is currently 35.58%.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.37% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Humana

Hedge funds and other institutional investors have recently bought and sold shares of the company. Dodge & Cox grew its holdings in shares of Humana by 106.7% during the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider’s stock worth $2,587,345,000 after purchasing an additional 5,264,045 shares during the last quarter. Vanguard Group Inc. grew its holdings in Humana by 15.8% during the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock worth $3,254,899,000 after acquiring an additional 1,751,857 shares during the last quarter. Norges Bank bought a new stake in Humana during the 4th quarter worth approximately $416,202,000. Pzena Investment Management LLC increased its position in Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock valued at $915,736,000 after acquiring an additional 1,103,132 shares during the period. Finally, Boston Partners raised its stake in shares of Humana by 435.8% during the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock valued at $279,236,000 after acquiring an additional 893,637 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.